Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-04-18 @ 6:55 PM
Study NCT ID:
NCT04519151
Status:
RECRUITING
Last Update Posted:
2023-06-08
First Post:
2020-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sponsor:
Organization: